ALB and urothelial carcinoma: A meta-analysis and a systematic review performed by Liu showed that decreased preoperative albumin in patients undergoing surgery for urothelial carcinoma predicted poor overall survival, cancer-specific survival, recurrence-free survival, 30-day complications after surgery, and 90-day mortality after surgery [16].